Peptide Synthesis Market
Global Peptide Synthesis Market Size, Share & Trends Analysis Report by Technology (Solid Phase, Liquid Phase, and Hybrid and Recombinant), By Product(Equipment, Reagents, Consumables, and Others) By End-User (Pharmaceutical and Biotechnology Companies, Contract Development and Manufacturing Organizations, and Academic and Research Institutes) Forecast Period (2021-2027)
The global peptide synthesis market is anticipated to grow at a significant CAGR of 6.5% during the forecast period. The growing adoption of peptides in biotechnology and pharmaceutical industry is driving the market growth. Peptide synthesis based vaccines are in the process of development against various pathogens, such as C virus, HIV-1, influenza virus and malaria. Diseases like Alzheimer and cancer are also being addressed by these vaccines. Peptide synthesis are being considerably used in the research efforts to fight with COVID-19 as well. The demand for peptides is also increasing for the treatment of cardiovascular and neurodegenerative diseases, renal failure, and rare diseases. Currently, there are more than 100 FDA-approved peptide-based drugs on the market. This number is expected to grow significantly, which in turn will create scope for the market growth.
However, the lack of unified regulations for peptides can limit the market growth. For instance, In October 2019, FDA approved a semaglutide oral tablets – Rybelsus, for control of blood sugar. It is a glucagon like peptide receptor protein treatment from Novo Nordisk.
Impact of COVID-19 Pandemic on Global Peptide Synthesis Market
The COVID-19 pandemic has made a positive influence on peptide synthesis market as peptides are increasingly being deployed and developed in the efforts of research of therapeutics for the COVID-19 treatment. Demand for peptide based drugs and vaccines has increased that leads to the development in the market. The COVID-19 has prompted biotechnology and pharmaceutical key players to invest in research of therapeutic and peptide based vaccines.
Segmental Outlook
The global peptide synthesis market is segmented based on the technology, product and services, and end-user. Based on the technology, the market is segmented into solid phase, liquid phase, and hybrid and recombinant. Based on the product and services, the market is sub-segmented into the equipmet, reagents and services. Based on the end-user, the market is sub-segmented into pharmaceutical and biotechnology companies, contract development and manufacturing organizations, and academic and research institutes. Among these, pharmaceutical and biotechnology companies are anticipated to hold a significant share in the makret owing to the adoption of peptides for the development of therapeutics.
Global Peptide Synthesis Market Share by Technology, 2020 (%)
The Solid Phase Segment Holds the Major Share in the Global Peptide Synthesis Market
Based on technology segment, it is anticipated that the solid phase peptide synthesis market will account for largest share in the market. The growth of this segment will be reinforced by its various advantages, such as high level automation, ease of operation, short production cycles and easy purification. Moreover, the solid phase have ability to synthesize long peptides from small amounts of amino acids due this they are highly useful in new drug development.
Regional Outlooks
The global peptide synthesis market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (China, India, Japan, South Korea, and Others), and the Rest of the World (The Middle East & Africa, and Latin America). Asia Pacific is expected to exhibit the fastest growth during the forecast period. The increasing investments by market players in the region, growing awareness about novel peptide treatments, and increasing healthcare spending by governments as well as patients are the prominent players accelerating the market growth.
Global Peptide Synthesis Market Growth, by Region 2021-2027
The North America Holds the Major Share in the Global Peptide Synthesis Market
Geographically,, the North America displayed the largest contribution in the the market in 2021, and it is further estimated to hold major share in the market during the forecast period. The regional growth is backed by the growing prevalence of chronic diseases, increasing R&D in biotechnology, escalating investment in drug developments by pharmaceutical companies are the prominent factors propelling the market growth in the region. Apart from these factors, the presence of major players and new developments by them is likely to contribute high to the market growth. Moreover, the growing prevalence of obesity due to changing lifestyles is going to offer enormouse growth opportunity to the market during the forecast period.
Market Players Outlook
The major companies serving the global peptide synthesis market include Thermo Fisher Scientific Inc., Merck KGaA, GenScript Biotech Corp., Bachem Holding AG, AAPPTec, Gyros Protein Technologies, Vivitide, Advanced ChemTech, Syngene International Ltd., Lonza Group Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, In August 2021, Novo Nordisk and Bachem Holding AG has entered into collaboration for a solid phase peptide synthesis technological advancement. Two separate studies were carried to discover solvent alternatives for the replacement of dichloromethane, reprotoxic N, N-methyl-2-pyrrolidone and N-dimethylformamide.
The Report Covers
• Market value data analysis of 2020 and forecast to 2027.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global peptide synthesis market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Peptide Synthesis Market
• Recovery Scenario of Global Peptide Synthesis Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. ThermoFisherScientific Inc.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Merck KGaA
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Kaneka Corp.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. GenScript Biotech Corp.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Bachem Holding AG
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Peptide Synthesis Market by Technology
4.1.1. Solid Phase
4.1.2. Liquid Phase
4.1.3. Hybrid and Recombinant
4.2. Global Peptide Synthesis Market by Product
4.2.1. Equipment
4.2.2. Reagents
4.2.3. Consumables
4.2.4. Others
4.3. Global Peptide Synthesis Market by End-User
4.3.1. Pharmaceutical& Biotechnology Companies
4.3.2. Contract Development & Manufacturing Organizations
4.3.3. Academic and Research Institutes
5. Regional Analysis
5.1. North America
5.1.1. US
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. AAPPTec
6.2. CSBio
6.3. CEM Corp.
6.4. Biotage AB
6.5. JPT Peptide Technologies
6.6. Gyros Protein Technologies
6.7. Advanced ChemTech
6.8. Creative Diagnostics, Inc
6.9. PolyPeptide Group
6.10. Syngene International Ltd.
6.11. Purolite Corp.
6.12. Lonza Group Ltd.
6.13. MP Biomedicals, LLC
6.14. Novo Nordisk A/S
6.15. Vivitide
1. GLOBAL PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
2. GLOBAL SOLID PHASE PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
3. GLOBAL LIQUID PHASE PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
4. GLOBAL HYBRID AND RECOMBINANT PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
5. GLOBAL PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
6. GLOBAL EQUIPMENT IN PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
7. GLOBAL REAGENTS IN PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
8. GLOBAL CONSUMABLES IN PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
9. GLOBAL OTHER PRODUCTS IN PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
10. GLOBAL PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
11. GLOBAL PEPTIDE SYNTHESIS FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
12. GLOBAL PEPTIDE SYNTHESIS FOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
13. GLOBAL PEPTIDE SYNTHESIS FOR ACADEMIC AND RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
14. GLOBAL PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
15. NORTH AMERICAN PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
16. NORTH AMERICAN PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
17. NORTH AMERICAN PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
18. NORTH AMERICAN PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
19. EUROPEAN PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
20. EUROPEAN PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
21. EUROPEAN PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
22. EUROPEAN PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
23. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
24. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
25. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
26. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
27. REST OF THE WORLD PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
28. REST OF THE WORLD PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
29. REST OF THE WORLD PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
30. REST OF THE WORLD PEPTIDE SYNTHESIS MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL PEPTIDE SYNTHESIS MARKET, 2020-2027 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL PEPTIDE SYNTHESIS MARKET BY SEGMENT, 2020-2027 ($ MILLION)
3. RECOVERY OF GLOBAL PEPTIDE SYNTHESIS MARKET, 2021-2027 (%)
4. GLOBAL PEPTIDE SYNTHESIS MARKET SHARE BY TECHNOLOGY, 2020 VS 2027 (%)
5. GLOBAL PEPTIDE SYNTHESIS MARKET SHARE BY PRODUCT, 2020 VS 2027 (%)
6. GLOBAL PEPTIDE SYNTHESIS MARKET SHARE BY END-USER, 2020 VS 2027 (%)
7. GLOBAL PEPTIDE SYNTHESIS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
8. GLOBAL SOLID PHASE PEPTIDE SYNTHESIS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
9. GLOBAL LIQUID PHASE PEPTIDE SYNTHESIS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
10. GLOBAL HYBRID AND RECOMBINANT PEPTIDE SYNTHESIS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
11. GLOBAL PEPTIDE SYNTHESIS EQUIPMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
12. GLOBAL PEPTIDE SYNTHESIS REAGENTS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
13. GLOBAL PEPTIDE SYNTHESIS SERVICES MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
14. GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES FOR PEPTIDE SYNTHESIS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
15. GLOBAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION FOR PEPTIDE SYNTHESIS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
16. GLOBAL ACADEMIC AND RESEARCH INSTITUTES FOR PEPTIDE SYNTHESIS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
17. US PEPTIDE SYNTHESIS MARKET SIZE, 2020-2027 ($ MILLION)
18. CANADA PEPTIDE SYNTHESIS MARKET SIZE, 2020-2027 ($ MILLION)
19. UK PEPTIDE SYNTHESIS MARKET SIZE, 2020-2027 ($ MILLION)
20. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, 2020-2027 ($ MILLION)
21. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, 2020-2027 ($ MILLION)
22. ITALY PEPTIDE SYNTHESIS MARKET SIZE, 2020-2027 ($ MILLION)
23. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, 2020-2027 ($ MILLION)
24. REST OF EUROPE PEPTIDE SYNTHESIS MARKET SIZE, 2020-2027 ($ MILLION)
25. INDIA PEPTIDE SYNTHESIS MARKET SIZE, 2020-2027 ($ MILLION)
26. CHINA PEPTIDE SYNTHESIS MARKET SIZE, 2020-2027 ($ MILLION)
27. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, 2020-2027 ($ MILLION)
28. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, 2020-2027 ($ MILLION)
29. REST OF ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, 2020-2027 ($ MILLION)
30. REST OF THE WORLD PEPTIDE SYNTHESIS MARKET SIZE, 2020-2027 ($ MILLION)
